Market Research Industry Reports

Bioverativ Inc (BIVV) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Bioverativ Inc (BIVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technology for the treatment of hemophilia A; and Alprolix, which comprises recombinant coagulation factor IX engineered using Fc fusion technology for the treatment of hemophilia B. The companys pipeline encompasses investigational candidates for the treatment of cold agglutinin disease, hemophilia A, beta thalassemia sickle cell disease, hemophilia B, and Sickle cell disease. Bioverativ sells its products in the US, the European Union (EU), New Zealand, Canada, Australia, Japan, Switzerland, Iceland, Liechtenstein, and Norway. Bioverativ is headquartered in Waltham, Massachusetts, the US.

Bioverativ Inc Key Recent Developments

Feb 13,2018: Bioverativ Reports Fourth Quarter and Full Year 2017 Performance
Oct 26,2017: Bioverativ Reports Third Quarter 2017 Performance
Aug 02,2017: Bioverativ Reports Second Quarter 2017 Performance
Jul 06,2017: New Data to be Presented at ISTH Underscore Bioverativs Commitment to Advance Hemophilia Care
May 15,2017: Bioverativ Appoints Geno J. Germano to Companys Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Bioverativ Inc - Key Facts 5
Bioverativ Inc - Key Employees 6
Bioverativ Inc - Key Employee Biographies 7
Bioverativ Inc - Major Products and Services 8
Bioverativ Inc - History 9
Bioverativ Inc - Company Statement 10
Bioverativ Inc - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 Company Analysis 13
Company Overview 13
Bioverativ Inc - Business Description 13
R&D Overview 13
Bioverativ Inc - Corporate Strategy 14
Bioverativ Inc - SWOT Analysis 15
SWOT Analysis - Overview 15
Bioverativ Inc - Strengths 15
Bioverativ Inc - Weaknesses 16
Bioverativ Inc - Opportunities 17
Bioverativ Inc - Threats 18
Bioverativ Inc - Key Competitors 19
Section 3 Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 Companys Lifesciences Financial Deals and Alliances 27
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Bioverativ Inc, Recent Deals Summary 29
Section 5 Companys Recent Developments 30
Feb 13, 2018: Bioverativ Reports Fourth Quarter and Full Year 2017 Performance 30
Oct 26, 2017: Bioverativ Reports Third Quarter 2017 Performance 32
Aug 02, 2017: Bioverativ Reports Second Quarter 2017 Performance 34
Jul 06, 2017: New Data to be Presented at ISTH Underscore Bioverativs Commitment to Advance Hemophilia Care 36
May 15, 2017: Bioverativ Appoints Geno J. Germano to Companys Board of Directors 38
May 03, 2017: Bioverativ Reports First Quarter 2017 Results 39
Apr 10, 2017: Bioverativ Appoints Tim Harris Executive Vice President, Research and Development 41
Mar 02, 2017: Anna Protopapas to Join Bioverativ Board of Directors 42
Mar 02, 2017: Anna Protopapas to Join Bioverativ Board of Directors 43
Section 6 Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48

List Of Tables

List of Tables
Bioverativ Inc, Key Facts 5
Bioverativ Inc, Key Employees 6
Bioverativ Inc, Key Employee Biographies 7
Bioverativ Inc, Major Products and Services 8
Bioverativ Inc, History 9
Bioverativ Inc, Other Locations 12
Bioverativ Inc, Subsidiaries 12
Bioverativ Inc, Key Competitors 19
Bioverativ Inc, Ratios based on current share price 20
Bioverativ Inc, Annual Ratios 21
Bioverativ Inc, Annual Ratios (Cont...1) 22
Bioverativ Inc, Annual Ratios (Cont...2) 23
Bioverativ Inc, Interim Ratios 25
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Bioverativ Inc, Recent Deals Summary 29
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47

List Of Figures

List of Figures
Bioverativ Inc, Performance Chart (2013 - 2017) 24
Bioverativ Inc, Ratio Charts 26
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

Bioverativ Inc (BIVV) - Medical Equipment - Deals and Alliances Profile

Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant

USD 250View Report

Bioverativ Inc (BIVV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant

USD 250View Report

Bioverativ Inc (BIVV) - Medical Equipment - Deals and Alliances Profile

Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant

USD 250View Report

Bioverativ Inc (BIVV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Mar 2018
No. of Pages :48
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube